Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tisporin vs Restasis in Moderate to Severe Dry Eye Disease
NCT02229955Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Dec 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tisporin in dry eye disease (DED), sponsored by Hanlim Pharm. Started Dec 2013; status: completed.
02
Drugs
Tisporin
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02229955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229955.